Artelo Biosciences, Inc. (ARTL)
NASDAQ·Healthcare·Biotechnology
$3.51
-6.80%
Mkt Cap $2.55M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 24, 2026 | — | — | — | -$4.71 | -$6.66 | -41.40% | — | — |
| Q4 2025 Nov 12, 2025 | — | — | — | -$0.82 | -$3.97 | -384.15% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$4.19 | -$5.61 | -33.89% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$0.80 | -$4.32 | -440.14% | — | — |
| Q1 2025 Mar 3, 2025 | — | — | — | -$2.62 | -$7.02 | -167.94% | — | — |
| Q4 2024 Nov 12, 2024 | — | — | — | -$4.75 | -$2.10 | +55.84% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$4.76 | -$4.50 | +5.46% | — | — |
| Q2 2024 May 13, 2024 | — | — | — | -$5.88 | -$4.68 | +20.41% | — | — |
| Q1 2024 Mar 25, 2024 | — | — | — | -$3.34 | -$5.94 | -77.84% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$3.88 | -$4.98 | -28.35% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.81 | -$0.56 | +30.86% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.93 | -$0.76 | +18.28% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.73 | -$1.18 | -61.64% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$0.91 | -$0.82 | +9.89% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$0.85 | -$0.90 | -5.88% | — | — |
| Q2 2022 May 12, 2022 | — | — | — | -$1.27 | -$0.75 | +40.94% | — | — |
| Q1 2022 Jan 12, 2022 | — | — | — | -$0.82 | -$7.19 | -771.52% | — | — |
| Q4 2021 Nov 29, 2021 | — | — | — | -$1.35 | -$6.30 | -366.67% | — | — |
| Q3 2021 Jul 12, 2021 | — | — | — | -$0.09 | -$8.99 | -9888.89% | — | — |
| Q2 2021 Apr 13, 2021 | — | — | — | -$0.11 | -$9.89 | -8890.91% | — | — |